Jul 04, 2023 Increased interest in the use of psychedelics as mainstream therapies By Josh Price Psychedelics have been under investigation by academics, clinicians and pharmaceutical companies for some time and the momentum and...
May 22, 2023 AI as a Medical Device By Sophie Vo To add to all the chatter about AI, let’s talk about AI as a medical device. Last month, the Medicines & Healthcare products Regulatory...
May 10, 2023 Proposed updates to the regulation of medical devices By Sophie Vo While it might be challenging for manufacturers of medical devices to navigate the evolving regulations of medical devices in Great...
Apr 03, 2023 The Windsor Framework: One Step Closer to a Single UK market By Pieter Erasmus Following the coming into force of the Windsor Agreement on 25 March 2023, we take a look at what this means in practice for the UK...
Mar 20, 2023 UK Spring Budget – Streamlining regulation and plans for growth in life sciences By Sally Shorthose Sophie Vo As part of last week’s Spring Budget, the UK Chancellor, Jeremy Hunt, announced increased funding of £10 million for the Medicines and...
Jan 31, 2023 Guide to EU and UK Pharmaceutical Regulatory Law 2023 By Sally Shorthose Eighth Edition, Edited by Sally Shorthose The Guide to EU and UK Pharmaceutical Regulatory Law is a unique volume that provides...
Dec 23, 2022 UK Supreme Court to assess plausibility of anaemia patents By Heidi Hurdle The UK Supreme Court has just confirmed that it will hear the appeal in FibroGen Inc v Akebia Therapeutics concerning patents for...